Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping

Author(s):  Tong Henry H Y, Chan Hokman, Du Zhen, Zheng Ying

Issue:  Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue

Page(s):  342-345

Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Page 1
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Page 2
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Page 3
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Page 4

Download in electronic PDF format for $75

Abstract:  The objective of this study was to evaluate by dissolution profiles mapping five extemporaneous oral itraconazole suspensions reported in literature. Dissolution profiles of the extemporaneous oral itraconazole preparations were mapped and correlated with their reported clinical data therein. Four out of five extemporaneous preparations had either too early or insufficient release of itraconazole during dissolution study, potentially limiting the in vivo oral bioavailability in patients. Dissolution profile in the remaining extemporaneous preparation was closely similar to that in commercial itraconazole capsules. Based on the reported clinical data and dissolution results in this study, the extemporaneous preparation proposed in a study by Ong and Fobes seems to be the most reasonable choice for our patients. Dissolution profile evaluation is an important quality-control parameter during the evaluation of extemporaneous preparations by pharmacists.

Related Keywords: Henry H.Y. Tong, PhD, RPh, Hokman Chan, BSc, Zhen Du, Mphil, Ying Zheng, PhD, itraconazole oral suspensions, antifungal agents, dissolution profile mapping, stability, bioavailability, literature review, formulations

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES, QUALITY CONTROL, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE, LITERATURE REVIEW

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping
Tong Henry H Y
, Chan Hokman, Du Zhen, Zheng Ying
Jul/Aug 2010
Pg. 342-345

Stability of Extemporaneous Oral Ribavirin Liquid Preparation
Chan John P
, Tong Henry H Y, Chow Alber H L
Nov/Dec 2004
Pg. 486-488

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Itraconazole 40-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 301

Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Spennacchio Antonio
, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jan/Feb 2023
Pg. 72-77

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets
Zaid Abdel Naser
, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu
Mar/Apr 2014
Pg. 169-174

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Sep/Oct 2021
Pg. 431-439

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser
, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
Nov/Dec 2021
Pg. 523-527

Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila
, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Mar/Apr 2017
Pg. 160-163

Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Espana B
, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
Jul/Aug 2020
Pg. 327-336

Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo.
Allen Loyd V Jr
Mar/Apr 2004
Pg. 107-109

Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji
, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2022
Pg. 65-71

Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt
Pramar Yahoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Jul/Aug 2023
Pg. 330-339

Nitazoxanide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2023
Pg. 420

Profile of a Practice: Don West, RPh, Lloyd Center Pharmacy, Portland, Oregon
Allen Loyd V Jr
Sep/Oct 2003
Pg. 350-352

Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A
, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2016
Pg. 257-261

Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice
, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017
Pg. 322-329

Return to Top